Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?

SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the sixth most frequently diagnosed cancer in men and the tenth in women with a rising incidence. The treatment of metastasized RCC has dramatically changed in the last decade, improving the overall survival of patients significantly. In this context, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelis, Jakob, Grabbert, Markus, Sigle, August, Yilmaz, Mehmet, Schlager, Daniel, Gratzke, Christian, Miernik, Arkadiusz, Schoeb, Dominik Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367545/
https://www.ncbi.nlm.nih.gov/pubmed/35954446
http://dx.doi.org/10.3390/cancers14153777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367545/
https://www.ncbi.nlm.nih.gov/pubmed/35954446
http://dx.doi.org/10.3390/cancers14153777

Ejemplares similares